AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Divalcad 250mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Cadila Pharmaceuticals Ltd

Salt Composition

Divalproex (250mg)

Overview Divalcad 250mg Tablet ER

Epileptic seizures and migraine prophylaxis are key indications for the extended-release Divalcad 250mg tablet. It's also sometimes prescribed for bipolar disorder management, either as monotherapy or in conjunction with other medications. Dosage and frequency are determined individually by your physician to optimize symptom control. Administer with or without food, consistently at the same time daily for maximum efficacy; therapeutic effects typically manifest within a couple of weeks. Continuous use, as directed, is crucial; interrupted dosing may precipitate seizures, and abrupt cessation can worsen your condition. Gradual discontinuation under medical supervision is essential. Common adverse reactions include nausea, vomiting, dizziness, drowsiness, visual disturbances, headache, unsteady gait, bruising, and hypothermia. While most are mild and transient, persistent or bothersome effects warrant medical consultation. Report skin rashes immediately. Prolonged therapy might reduce bone density (osteoporosis), increasing fracture risk. Suicidal ideation is a rare but serious potential side effect; report any mood changes promptly. Prior to initiating Divalcad 250mg, inform your doctor about any pre-existing heart, liver, or kidney conditions, urinary difficulties, or a history of depression or suicidal thoughts. Drug interactions are possible; disclose all medications to ensure safe concurrent use. Consult your physician before initiating or discontinuing Divalcad 250mg during pregnancy. Alcohol consumption should be avoided due to the potential for amplified side effects and increased seizure risk. Regular blood monitoring, both pre- and post-treatment initiation, is usually necessary to optimize dosage.

Uses of Divalcad 250mg Tablet ER

Managing epileptic seizures and bipolar disorder, and migraine prevention.

Major Benefits of Divalcad 250mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; do not break, crush, or chew it. Divalcad 250mg Extended-Release Tablets can be administered with or without food, however, consistent timing is recommended.

Common Side effects of Divalcad 250mg Tablet ER:

  • Decreased body temperature
  • Dizziness
  • Sleepiness
  • Tremors
  • Paresthesia (tingling or pricking sensation)
  • Anemia (low number of red blood cells)
  • Decreased sodium level in blood
  • Liver injury
  • Gastrointestinal disturbance
  • Hypersensitivity
  • Deafness
  • Urinary incontinence
  • Increase in body weight
  • Pain during periods

How to use Divalcad 250mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 250mg Divalcad Extended-Release tablet whole; avoid chewing, crushing, or breaking it. While you can take it with or without food, consistency is key – adhere to a regular daily schedule.

How Divalcad 250mg Tablet ER works:

Extended-release Divalcad 250mg tablets are used to manage epilepsy. Their mechanism of action involves reducing the hyperactivity of neurons in the brain, thereby controlling seizures.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Extended-release Divalcad 250mg tablets can induce increased sleepiness when combined with alcohol.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Divalcad 250mg tablets pose a confirmed risk to a developing fetus and should not be used during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known dangers. Physician consultation is advised.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Divalcad 250mg tablets are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.

DrivingDrivingUNSAFE

Extended-release Divalcad 250mg tablets can produce adverse reactions that might impair driving capabilities.

KidneyKidneySAFE IF PRESCRIBED

Extended-release Divalcad 250mg tablets are considered safe for use in individuals with impaired renal function. No alteration of the Divalcad 250mg extended-release tablet dosage is necessary.

LiverLiverUNSAFE

Extended-release Divalcad 250mg tablets are contraindicated in individuals with hepatic impairment and should be omitted. Physician consultation is advised.

What if you forget to take Divalcad 250mg Tablet ER :

Should you forget a Divalcad 250mg Extended-Release Tablet, take it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Divalcad 250mg Tablet ER

LabelValue
Chemical Type Derivatives of Aliphatic Carboxylic Acids
Developing Habits No.
Treatment Category Neuroscience of the Central Nervous System
Behavior Class Anti-epileptic drugs targeting sodium channels

FAQs on Divalcad 250mg Tablet ER

Always consult your doctor before discontinuing Divalcad 250mg Tablet ER. Withdrawal should be gradual, under medical supervision, to minimize the risk of symptom recurrence, including irritability, anxiety, dizziness, and tremors.
Divalcad 250mg Extended-Release tablets can act as a mood stabilizer in some cases, particularly for individuals experiencing rapid mood swings. This effect is achieved by reducing excessive brain activity associated with these mood changes.
Divalcad 250mg ER tablets can cause weight gain, possibly from increased appetite. Maintain a healthy diet and exercise to minimize this risk. Consult your doctor about any weight concerns.
Divalcad 250mg Extended-Release Tablets can cause drowsiness. Refrain from driving or operating machinery until you understand their effects on you.
Hair loss is a possible, temporary side effect of Divalproex Sodium 250mg Extended-Release tablets, often linked to dosage. Consult your doctor if this occurs or continues.
Divalcad 250mg Tablet ER can cause liver damage, particularly within the first six months of treatment. Symptoms may include nausea, vomiting, appetite loss, stomach pain, dark urine, facial swelling, and jaundice (yellowing of skin or eyes). Liver function tests are crucial before starting and regularly during the initial six months, especially for at-risk individuals or those with a history of liver problems.
Refrain from drinking alcohol during your Divalproex Sodium 250mg ER treatment. Combining alcohol with this medication can increase drowsiness, dizziness, or lightheadedness.
Before starting Divalcad 250mg Tablet ER, your doctor may order blood tests. These may include a complete blood count (with platelet count), bleeding time, and coagulation studies to minimize the risk of bleeding or bruising. Liver function tests are also recommended before and, for high-risk individuals or those with liver disease, regularly during the first six months of treatment.
Severe abdominal pain, nausea, and vomiting may indicate pancreatitis. Seek immediate medical attention if you experience these symptoms. Your doctor may order a serum amylase test; a positive result requires immediate medication cessation.
Divalcad 250mg ER tablet overdose can lead to headaches, blurred vision (from constricted pupils), reduced reflexes, confusion, and fatigue. Further symptoms may include muscle weakness, seizures, loss of consciousness, altered behavior, and respiratory problems like rapid breathing, shortness of breath, or chest pain. Seek immediate medical help if an overdose occurs.
Divalcad 250mg Tablet ER
61
MRP 74
17% off